Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

YKL-40 is directly produced by tumor cells and is inversely linked to EGFR in glioblastomas.

Horbinski C, Wang G, Wiley CA.

Int J Clin Exp Pathol. 2010 Jan 1;3(3):226-37.

2.

Protein and mRNA levels of YKL-40 in high-grade glioma.

Kazakova MH, Staneva DN, Koev IG, Staikov DG, Mateva N, Timonov PT, Miloshev GA, Sarafian VS.

Folia Biol (Praha). 2014;60(6):261-7.

3.

Alpha internexin expression related with molecular characteristics in adult glioblastoma and oligodendroglioma.

Suh JH, Park CK, Park SH.

J Korean Med Sci. 2013 Apr;28(4):593-601. doi: 10.3346/jkms.2013.28.4.593. Epub 2013 Mar 27.

4.

YKL-40 expression is associated with poorer response to radiation and shorter overall survival in glioblastoma.

Pelloski CE, Mahajan A, Maor M, Chang EL, Woo S, Gilbert M, Colman H, Yang H, Ledoux A, Blair H, Passe S, Jenkins RB, Aldape KD.

Clin Cancer Res. 2005 May 1;11(9):3326-34.

5.

Association between YKL-40 and adult primary astrocytoma.

Zhang W, Kawanishi M, Miyake K, Kagawa M, Kawai N, Murao K, Nishiyama A, Fei Z, Zhang X, Tamiya T.

Cancer. 2010 Jun 1;116(11):2688-97. doi: 10.1002/cncr.25084.

6.

YKL-40 is a differential diagnostic marker for histologic subtypes of high-grade gliomas.

Nutt CL, Betensky RA, Brower MA, Batchelor TT, Louis DN, Stemmer-Rachamimov AO.

Clin Cancer Res. 2005 Mar 15;11(6):2258-64.

7.

Fluorescence in situ hybridization for 1p, 19q status in a cohort of glial neoplasms.

Singh VY, Chacko G, Chacko AG, Rajshekhar V.

Neurol India. 2014 Jan-Feb;62(1):32-6. doi: 10.4103/0028-3886.128275. Erratum in: Neurol India. 2014 Mar-Apr;62(2):191.

8.

Expression of oligodendroglial and astrocytic lineage markers in diffuse gliomas: use of YKL-40, ApoE, ASCL1, and NKX2-2.

Rousseau A, Nutt CL, Betensky RA, Iafrate AJ, Han M, Ligon KL, Rowitch DH, Louis DN.

J Neuropathol Exp Neurol. 2006 Dec;65(12):1149-56.

PMID:
17146289
9.

High CHI3L1 expression is associated with glioma patient survival.

Steponaitis G, Skiriutė D, Kazlauskas A, Golubickaitė I, Stakaitis R, Tamašauskas A, Vaitkienė P.

Diagn Pathol. 2016 Apr 27;11:42. doi: 10.1186/s13000-016-0492-4.

10.

YKL-40 and matrix metalloproteinase-9 as potential serum biomarkers for patients with high-grade gliomas.

Hormigo A, Gu B, Karimi S, Riedel E, Panageas KS, Edgar MA, Tanwar MK, Rao JS, Fleisher M, DeAngelis LM, Holland EC.

Clin Cancer Res. 2006 Oct 1;12(19):5698-704.

11.

ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an "integrated" diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma.

Reuss DE, Sahm F, Schrimpf D, Wiestler B, Capper D, Koelsche C, Schweizer L, Korshunov A, Jones DT, Hovestadt V, Mittelbronn M, Schittenhelm J, Herold-Mende C, Unterberg A, Platten M, Weller M, Wick W, Pfister SM, von Deimling A.

Acta Neuropathol. 2015 Jan;129(1):133-46. doi: 10.1007/s00401-014-1370-3. Epub 2014 Nov 27.

12.

Prognostic significance of histological grading, p53 status, YKL-40 expression, and IDH1 mutations in pediatric high-grade gliomas.

Antonelli M, Buttarelli FR, Arcella A, Nobusawa S, Donofrio V, Oghaki H, Giangaspero F.

J Neurooncol. 2010 Sep;99(2):209-15. doi: 10.1007/s11060-010-0129-5. Epub 2010 Feb 21.

PMID:
20174854
13.
14.

Immunohistochemical detection of EGFRvIII in high malignancy grade astrocytomas and evaluation of prognostic significance.

Aldape KD, Ballman K, Furth A, Buckner JC, Giannini C, Burger PC, Scheithauer BW, Jenkins RB, James CD.

J Neuropathol Exp Neurol. 2004 Jul;63(7):700-7.

PMID:
15290895
16.

Assessment of 1p/19q status by fluorescence in situ hybridization assay: A comparative study in oligodendroglial, mixed oligoastrocytic and astrocytic tumors.

Shukla B, Agarwal S, Suri V, Pathak P, Sharma MC, Gupta D, Sharma BS, Suri A, Halder A, Sarkar C.

Neurol India. 2009 Sep-Oct;57(5):559-66. doi: 10.4103/0028-3886.57795.

17.

[Mutation of isocitrate dehydrogenase gene in Chinese patients with glioma].

Pan Y, Qi XL, Wang LM, Dong RF, Zhang M, Zheng DF, Chang Q, Zhong YF.

Zhonghua Bing Li Xue Za Zhi. 2013 May;42(5):292-8. doi: 10.3760/cma.j.issn.0529-5807.2013.05.002. Chinese.

PMID:
24004584
18.

Regulation of YKL-40 expression during genotoxic or microenvironmental stress in human glioblastoma cells.

Junker N, Johansen JS, Hansen LT, Lund EL, Kristjansen PE.

Cancer Sci. 2005 Mar;96(3):183-90.

19.

[Correlation between loss of heterozygosity on chromosome 1p and 19q and expression of MGMT, p53 and Ki-67 proteins in gliomas].

Huang L, Jiang T, Yuan F, Li GL, Xu LX, Cui Y.

Zhonghua Zhong Liu Za Zhi. 2011 Oct;33(10):752-8. Chinese.

PMID:
22335907
20.

Supplemental Content

Support Center